Delivery Order SPE2DR25D7056-SPE2DR26FV8RF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $1,411.51. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. Sumatriptan is a migraine treatment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $14,646.60. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,137.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, awarded on July 23, 2025, with a completion date of July 24, 2025, utilizes firm fixed pricing with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,248.57 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 ml auto-injector units. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a firm fixed price delivery order with no set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,733.91 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injectors on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $2,299.66. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the established pharmaceutical distributor. The delivery order is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, and is scheduled for completion by September 19, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,522.48 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector, a migraine treatment medication. This firm fixed-price, non-set-aside contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $2,115.21. The order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a firm fixed-price transaction with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $2,380.11 delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injectors on June 2, 2025, with completion scheduled for June 3, 2025. This non-competitive, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.62 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on October 24, 2025, with completion scheduled for October 27, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug...
- SPE2DR25D7056Indefinite Delivery Contract
- SPE2DR25D7056-SPE2DR26FV8RFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,790.64 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on December 16, 2025, with an ultimate completion date of December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a broad range of medications and medical supplies to support Department of Defense health systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains through open competition. This delivery order for migraine treatment medication represents one of many individual orders fulfilled under the larger prime vendor contract that enables the company to supply essential pharmaceuticals and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/15/25 |